Sitryx
Sitryx is a biopharmaceutical company focussed on regulating cell metabolism to develop disease-modifying therapeutics for patients with chronic autoimmune and inflammatory diseases.
- What
- Life Sciences
- When
- Oct 2018
- CEO
- Neil Weir
- Status
- Private
- Investment
- Active
- OSE Board Director
- Sanne de Jongh